| succimer 100 MG Oral Capsule [Chemet] succimer | 3,507 | 69.2%
| T4 | 14.1% | 24 |
| dibasic potassium phosphate 0.26 MG/ML / glucose 50 MG/ML / magnesium chloride 0.00373 MEQ/ML / potassium chloride 0.00174 MEQ/ML / sodium acetate 0.039 MEQ/ML Injectable Solution [Isolyte P] dibasic potassium phosphate | 3,507 | 69.2%
| T3 | 1.9% | - |
| 1 ML galcanezumab-gnlm 100 MG/ML Prefilled Syringe [Emgality] galcanezumab-gnlm | 3,506 | 69.2%
| T3 | 98.5% | - |
| letermovir 120 MG Oral Pellet [Prevymis] letermovir | 3,505 | 69.2%
| T4 | 76.1% | 2,391 |
| cefotetan 1000 MG Injection cefotetan | 3,500 | 69.1%
| T3 | 0% | 20 |
| cefotetan 2000 MG Injection cefotetan | 3,496 | 69%
| T3 | 0% | 20 |
| methylphenidate hydrochloride 1 MG/ML Oral Solution methylphenidate hydrochloride | 3,493 | 68.9%
| T3 | 34.1% | 108,959 |
| benzoyl peroxide 0.05 MG/MG / erythromycin 0.03 MG/MG Topical Gel benzoyl peroxide | 3,491 | 68.9%
| T3 | 0% | 465 |
| 3 ML icatibant 10 MG/ML Prefilled Syringe [Sajazir] icatibant | 3,480 | 68.7%
| T4 | 99% | 43 |
| calcium chloride 0.23 MEQ/ML / magnesium chloride 0.53 MEQ/ML / potassium chloride 0.1 MEQ/ML / sodium acetate 1.48 MEQ/ML / sodium chloride 0.27 MEQ/ML Injectable Solution calcium chloride | 3,477 | 68.6%
| T3 | 73.4% | 108,459 |
| {7 (ethinyl estradiol 0.01 MG Oral Tablet) / 84 (ethinyl estradiol 0.03 MG / levonorgestrel 0.15 MG Oral Tablet) } Pack [Jaimiess 91 Day] ethinyl estradiol | 3,477 | 68.6%
| T2 | 0% | - |
| ivacaftor 50 MG Oral Granules [Kalydeco] ivacaftor | 3,464 | 68.4%
| T4 | 99.7% | 91 |
| ivacaftor 75 MG Oral Granules [Kalydeco] ivacaftor | 3,464 | 68.4%
| T4 | 99.7% | 91 |
| ivacaftor 25 MG Oral Granules [Kalydeco] ivacaftor | 3,464 | 68.4%
| T4 | 99.7% | 91 |
| 0.67 ML anakinra 149 MG/ML Prefilled Syringe [Kineret] anakinra | 3,460 | 68.3%
| T4 | 99.1% | 770 |
| 100 ML potassium chloride 0.1 MEQ/ML Injection potassium chloride | 3,455 | 68.2%
| T3 | 1.3% | - |
| phenytoin sodium 200 MG Extended Release Oral Capsule [Phenytek] phenytoin sodium | 3,453 | 68.1%
| T2 | 0% | 11 |
| phenytoin sodium 300 MG Extended Release Oral Capsule [Phenytek] phenytoin sodium | 3,453 | 68.1%
| T2 | 0% | 11 |
| {7 (ethinyl estradiol 0.01 MG Oral Tablet) / 84 (ethinyl estradiol 0.02 MG / levonorgestrel 0.1 MG Oral Tablet) } Pack [CamreseLo 91 Day] ethinyl estradiol | 3,452 | 68.1%
| T3 | 0% | - |
| hydroxyzine pamoate 100 MG Oral Capsule hydroxyzine pamoate | 3,446 | 68%
| T2 | 28.2% | 419,149 |
| ivacaftor 188 MG / lumacaftor 150 MG Oral Granules [ORKAMBI] ivacaftor | 3,445 | 68%
| T4 | 99.2% | 91 |
| ivacaftor 125 MG / lumacaftor 100 MG Oral Granules [ORKAMBI] ivacaftor | 3,445 | 68%
| T4 | 99.2% | 91 |
| ivacaftor 94 MG / lumacaftor 75 MG Oral Granules [ORKAMBI] ivacaftor | 3,443 | 67.9%
| T4 | 99.2% | 91 |
| ciclopirox 10 MG/ML Medicated Shampoo ciclopirox | 3,440 | 67.9%
| T2 | 0% | 397,306 |
| abiraterone acetate 500 MG Oral Tablet abiraterone acetate | 3,440 | 67.9%
| T4 | 95.2% | 45,661 |
| colesevelam hydrochloride 3750 MG Powder for Oral Suspension colesevelam hydrochloride | 3,436 | 67.8%
| T3 | 0% | 66,749 |
| 1 ML epoetin alfa 2000 UNT/ML Injection [Procrit] epoetin alfa | 3,436 | 67.8%
| T3 | 98% | 24,380 |
| 1 ML epoetin alfa 3000 UNT/ML Injection [Procrit] epoetin alfa | 3,436 | 67.8%
| T3 | 98% | 24,380 |
| 1 ML epoetin alfa 4000 UNT/ML Injection [Procrit] epoetin alfa | 3,436 | 67.8%
| T3 | 98% | 24,380 |
| 1 ML epoetin alfa 10000 UNT/ML Injection [Procrit] epoetin alfa | 3,436 | 67.8%
| T3 | 98% | 24,380 |
| epoetin alfa 20000 UNT/ML Injectable Solution [Procrit] epoetin alfa | 3,436 | 67.8%
| T4 | 98% | 24,380 |
| 1 ML epoetin alfa 40000 UNT/ML Injection [Procrit] epoetin alfa | 3,436 | 67.8%
| T4 | 98% | 24,380 |
| brimonidine tartrate 2 MG/ML / timolol 5 MG/ML Ophthalmic Solution [Combigan] brimonidine tartrate | 3,422 | 67.5%
| T3 | 0% | 573,214 |
| potassium chloride 20 MEQ Powder for Oral Solution [Klor-Con] potassium chloride | 3,414 | 67.4%
| T3 | 0% | 3,479,756 |
| fluocinolone acetonide 0.1 MG/ML Otic Solution [Flac] fluocinolone acetonide | 3,411 | 67.3%
| T3 | 0% | 80,799 |
| ivacaftor 13.4 MG Oral Granules [Kalydeco] ivacaftor | 3,407 | 67.2%
| T4 | 99.7% | 91 |
| ivacaftor 5.8 MG Oral Granules [Kalydeco] ivacaftor | 3,407 | 67.2%
| T4 | 99.7% | 91 |
| triamcinolone acetonide 5 MG/ML Topical Cream [Triderm] triamcinolone acetonide | 3,398 | 67.1%
| T2 | 0% | 3,621,019 |
| magnesium chloride 0.00148 MEQ/ML / monobasic potassium phosphate 0.0082 MG/ML / potassium chloride 0.00497 MEQ/ML / sodium acetate 0.0272 MEQ/ML / sodium chloride 0.0906 MEQ/ML / sodium gluconate 5 MG/ML / sodium phosphate, dibasic 0.12 MG/ML Injectable Solution [Isolyte S] magnesium chloride | 3,397 | 67%
| T3 | 9.3% | - |
| dexamethasone 0.001 MG/MG / tobramycin 0.003 MG/MG Ophthalmic Ointment [Tobradex] dexamethasone | 3,389 | 66.9%
| T3 | 0% | 850,184 |
| dutasteride 0.5 MG / tamsulosin hydrochloride 0.4 MG Oral Capsule dutasteride | 3,384 | 66.8%
| T3 | 0% | 224,682 |
| {28 (ethinyl estradiol 0.0025 MG / norethindrone acetate 0.5 MG Oral Tablet) } Pack ethinyl estradiol | 3,377 | 66.6%
| T3 | 3.3% | - |
| hydralazine hydrochloride 37.5 MG / isosorbide dinitrate 20 MG Oral Tablet hydralazine hydrochloride | 3,373 | 66.6%
| T3 | 0% | 1,411,222 |
| 120 ACTUAT albuterol 0.09 MG/ACTUAT / budesonide 0.08 MG/ACTUAT Metered Dose Inhaler [Airsupra] | 3,367 | 66.4%
| T3 | 1.4% | 1,487 |
| glecaprevir 100 MG / pibrentasvir 40 MG Oral Tablet [Mavyret] glecaprevir | 3,364 | 66.4%
| T4 | 99.6% | 8,771 |
| acetaminophen 325 MG / tramadol hydrochloride 37.5 MG Oral Tablet acetaminophen | 3,362 | 66.4%
| T2 | 1% | 156 |
| bazedoxifene 20 MG / estrogens, conjugated (USP) 0.45 MG Oral Tablet [Duavee] bazedoxifene | 3,361 | 66.3%
| T3 | 15.7% | - |
| ethinyl estradiol 0.005 MG / norethindrone acetate 1 MG Oral Tablet [Jinteli] ethinyl estradiol | 3,357 | 66.3%
| T3 | 4.7% | 3,693 |
| {7 (ethinyl estradiol 0.01 MG Oral Tablet) / 84 (ethinyl estradiol 0.02 MG / levonorgestrel 0.1 MG Oral Tablet) } Pack [Lojaimiess 91 Day] ethinyl estradiol | 3,345 | 66%
| T2 | 0% | - |
| erythromycin 0.02 MG/MG Topical Gel erythromycin | 3,342 | 66%
| T2 | 0% | 1,861 |
| ethinyl estradiol 0.005 MG / norethindrone acetate 1 MG Oral Tablet [Fyavolv] ethinyl estradiol | 3,341 | 65.9%
| T3 | 3.8% | 3,693 |
| potassium chloride 15 MEQ Extended Release Oral Tablet potassium chloride | 3,337 | 65.9%
| T2 | 0% | 3,479,756 |
| levodopa 42 MG Inhalation Powder [Inbrija] levodopa | 3,337 | 65.9%
| T4 | 97.9% | 2,486 |
| 30 ACTUAT umeclidinium 0.0625 MG/ACTUAT Dry Powder Inhaler [Incruse] | 3,336 | 65.8%
| T3 | 0% | - |
| rivaroxaban 1 MG/ML Oral Suspension [Xarelto] rivaroxaban | 3,330 | 65.7%
| T3 | 0% | 1,324,165 |
| pirfenidone 534 MG Oral Tablet pirfenidone | 3,328 | 65.7%
| T4 | 99.5% | 7,776 |
| 120 ACTUAT fluticasone propionate 0.045 MG/ACTUAT / salmeterol 0.021 MG/ACTUAT Metered Dose Inhaler [Advair] | 3,325 | 65.6%
| T3 | 0% | - |
| 120 ACTUAT fluticasone propionate 0.115 MG/ACTUAT / salmeterol 0.021 MG/ACTUAT Metered Dose Inhaler [Advair] | 3,325 | 65.6%
| T3 | 0% | - |
| 120 ACTUAT fluticasone propionate 0.23 MG/ACTUAT / salmeterol 0.021 MG/ACTUAT Metered Dose Inhaler [Advair] | 3,325 | 65.6%
| T3 | 0% | - |
| clindamycin 10 MG/ML Medicated Pad clindamycin | 3,320 | 65.5%
| T2 | 0% | 8,722 |
| fenofibric acid 135 MG Delayed Release Oral Capsule fenofibric acid | 3,317 | 65.5%
| T2 | 0% | 40,800 |
| ethinyl estradiol 0.0025 MG / norethindrone acetate 0.5 MG Oral Tablet [Fyavolv] ethinyl estradiol | 3,314 | 65.4%
| T3 | 3.4% | 3,693 |
| empagliflozin 5 MG / metformin hydrochloride 500 MG Oral Tablet [Synjardy] empagliflozin | 3,307 | 65.3%
| T3 | 0% | 1,882,768 |
| fenofibrate 43 MG Oral Capsule fenofibrate | 3,307 | 65.3%
| T2 | 0% | 500,170 |
| estrogens, conjugated (USP) 0.3 MG Oral Tablet [Premarin] estrogens, | 3,305 | 65.2%
| T3 | 8.2% | 241,518 |
| estrogens, conjugated (USP) 0.45 MG Oral Tablet [Premarin] estrogens, | 3,305 | 65.2%
| T3 | 8.2% | 241,518 |
| estrogens, conjugated (USP) 0.625 MG Oral Tablet [Premarin] estrogens, | 3,305 | 65.2%
| T3 | 8.2% | 241,518 |
| estrogens, conjugated (USP) 0.9 MG Oral Tablet [Premarin] estrogens, | 3,305 | 65.2%
| T3 | 8.2% | 241,518 |
| estrogens, conjugated (USP) 1.25 MG Oral Tablet [Premarin] estrogens, | 3,305 | 65.2%
| T3 | 8.2% | 241,518 |
| fenofibric acid 45 MG Delayed Release Oral Capsule fenofibric acid | 3,305 | 65.2%
| T2 | 0% | 40,800 |
| 24 HR lamotrigine 50 MG Extended Release Oral Tablet lamotrigine | 3,305 | 65.2%
| T3 | 0% | - |
| empagliflozin 12.5 MG / metformin hydrochloride 1000 MG Oral Tablet [Synjardy] empagliflozin | 3,303 | 65.2%
| T3 | 0% | 1,882,768 |
| empagliflozin 5 MG / metformin hydrochloride 1000 MG Oral Tablet [Synjardy] empagliflozin | 3,303 | 65.2%
| T3 | 0% | 1,882,768 |
| empagliflozin 12.5 MG / metformin hydrochloride 500 MG Oral Tablet [Synjardy] empagliflozin | 3,303 | 65.2%
| T3 | 0% | 1,882,768 |
| 24 HR empagliflozin 10 MG / metformin hydrochloride 1000 MG Extended Release Oral Tablet [Synjardy] empagliflozin | 3,303 | 65.2%
| T3 | 0% | 35,768 |
| 24 HR empagliflozin 5 MG / metformin hydrochloride 1000 MG Extended Release Oral Tablet [Synjardy] empagliflozin | 3,303 | 65.2%
| T3 | 0% | 35,768 |
| 24 HR empagliflozin 25 MG / metformin hydrochloride 1000 MG Extended Release Oral Tablet [Synjardy] empagliflozin | 3,303 | 65.2%
| T3 | 0% | 35,768 |
| 24 HR empagliflozin 12.5 MG / metformin hydrochloride 1000 MG Extended Release Oral Tablet [Synjardy] empagliflozin | 3,303 | 65.2%
| T3 | 0% | 35,768 |
| 24 HR lamotrigine 100 MG Extended Release Oral Tablet lamotrigine | 3,302 | 65.2%
| T3 | 0% | - |
| letermovir 20 MG Oral Pellet [Prevymis] letermovir | 3,299 | 65.1%
| T5 | 70.5% | 2,391 |
| desonide 0.0005 MG/MG Topical Ointment desonide | 3,289 | 64.9%
| T3 | 0% | 101,247 |
| 24 HR lamotrigine 300 MG Extended Release Oral Tablet lamotrigine | 3,285 | 64.8%
| T3 | 0% | - |
| 24 HR lamotrigine 25 MG Extended Release Oral Tablet lamotrigine | 3,285 | 64.8%
| T3 | 0% | - |
| 24 HR lamotrigine 200 MG Extended Release Oral Tablet lamotrigine | 3,285 | 64.8%
| T3 | 0% | - |
| 500 ML olive oil 160 MG/ML / soybean oil 40 MG/ML Injection [Clinolipid] olive oil | 3,283 | 64.8%
| T3 | 98.9% | 1,107 |
| methylphenidate hydrochloride 2 MG/ML Oral Solution methylphenidate hydrochloride | 3,278 | 64.7%
| T3 | 36.4% | 108,959 |
| perfluorohexyloctane 1340 MG/ML Ophthalmic Solution [Miebo] perfluorohexyloctane | 3,257 | 64.3%
| T3 | 17.7% | 6,324 |
| glecaprevir 50 MG / pibrentasvir 20 MG Oral Pellet [Mavyret] glecaprevir | 3,256 | 64.3%
| T4 | 99.6% | 8,771 |
| 84 HR estradiol 0.00104 MG/HR Transdermal System [Lyllana] estradiol | 3,251 | 64.2%
| T3 | 1.5% | 5,567 |
| 84 HR estradiol 0.00156 MG/HR Transdermal System [Lyllana] estradiol | 3,251 | 64.2%
| T3 | 1.5% | 5,567 |
| 84 HR estradiol 0.00208 MG/HR Transdermal System [Lyllana] estradiol | 3,251 | 64.2%
| T3 | 1.5% | 5,567 |
| 84 HR estradiol 0.00313 MG/HR Transdermal System [Lyllana] estradiol | 3,251 | 64.2%
| T3 | 1.5% | 5,567 |
| 84 HR estradiol 0.00417 MG/HR Transdermal System [Lyllana] estradiol | 3,251 | 64.2%
| T3 | 1.5% | 5,567 |
| acetaminophen 325 MG / hydrocodone bitartrate 2.5 MG Oral Tablet acetaminophen | 3,248 | 64.1%
| T2 | 3.1% | 156 |
| cefixime 20 MG/ML Oral Suspension cefixime | 3,245 | 64%
| T3 | 0% | 11,613 |
| cefixime 40 MG/ML Oral Suspension cefixime | 3,245 | 64%
| T3 | 0% | 11,613 |
| Pediatric 1 ML leuprolide acetate 7.5 MG/ML Prefilled Syringe [Lupron] Pediatric | 3,243 | 64%
| T4 | 92.5% | - |
| acetaminophen 21.7 MG/ML / hydrocodone bitartrate 0.67 MG/ML Oral Solution acetaminophen | 3,238 | 63.9%
| T3 | 0% | 156 |
| 24 HR paroxetine hydrochloride 12.5 MG Extended Release Oral Tablet paroxetine hydrochloride | 3,228 | 63.7%
| T3 | 26.5% | - |
| 24 HR paroxetine hydrochloride 25 MG Extended Release Oral Tablet paroxetine hydrochloride | 3,228 | 63.7%
| T3 | 26.5% | - |